Accordingly, growth factors such as TGF-β and hepatocyte growth factor (HGF, or its receptor c-Met) that are involved in cancer-stromal interactions and EMT have been well studied in order to develop therapeutic strategies targeting these factors [53,54]. The gene discussed is HGF; the disease is cancer.